Isatuximab-mediated CDC was only observed in MM and DLBCL cell lines with high CD38 receptor density and low surface densities of the CDC inhibitors CD46, CD55, and CD59. This evidence concerns the gene CD46 and diffuse large B-cell lymphoma.